June 23, 2017 8:08 PM ET


Company Overview of Dalian Hissen BioPharm Co., Ltd.

Company Overview

Dalian Hissen BioPharm Co., Ltd., a bio-pharmaceutical enterprise, engages in the research and development, production, and sale of vaccine in China. It offers influenza vaccine and recombinant hepatitis B vaccine. The company was founded in 1993 and is based in Dalian, China. It operates a technology development center in Liaoning, China. As of July 9, 2015, Dalian Hissen BioPharm Co., Ltd. operates as a subsidiary of Liaoning Aimei Biological Vaccine Technology Group Co., Ltd.

35 Wanda Road

Economic and Technological Development Zone

Dalian,  116100


Founded in 1993


86 411 87407585


86 411 87549798

Key Executives for Dalian Hissen BioPharm Co., Ltd.

General Manager
Compensation as of Fiscal Year 2016.

Dalian Hissen BioPharm Co., Ltd. Key Developments

Dalian Hissen BioPharm Co., Ltd. Presents at ChinaBio Partnering Forum 2016, May-18-2016

Dalian Hissen BioPharm Co., Ltd. Presents at ChinaBio Partnering Forum 2016, May-18-2016 . Venue: Suzhou, China.

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Dalian Hissen BioPharm Co., Ltd., please visit www.hissen.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.